Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study.
Mei-Na PiaoJing XieMin-Min JinXiao-Ting MaZheng DouJian-Ping WangJin-Li LiPublished in: Translational lung cancer research (2024)
Our preliminary research shows that SBRT combined with immunotherapy has a good effect, and NLR after SBRT is a poor prognostic factor for OS. Larger PTV volume is associated with decreased ALC after SBRT.